エクソソーム研究市場 : 2026年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2022年4月

エクソソーム研究市場 : 製品とサービス(キット、試薬、機器)、適応(がん、感染症)、用途(バイオマーカー、ワクチン)、製造サービス(幹細胞、樹状細胞由来)、エンドユーザー – 2026年までの世界予測

Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User – Global Forecast to 2026

ページ数 183
図表数 261
種別 英文調査報告書
価格

レポート目次    お問合せ・ご注文    価格・納期について

無料サンプル

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures.


“By product & service, the kits & reagents segment accounted for the largest share of the exosome research market”
Based on product and service, the exosomes market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is further divided into antibodies, isolation, purification, quantitation kits & reagents, and other kits & reagents. Circulating exosomal microRNAs (miRNAs) have emerged as valuable biomarker candidates, making it imperative to characterize these exosomes carefully. This has propelled the use of these entities in exosome research to develop easy-to-use kits and reagents. Additionally, isolation and purification are critical steps in exosome research protocols, contributing to their large-scale adoption in the market.
“Asia Pacific: The fastest-growing region in the exosome research market.”
The Asia Pacific exosome research market is registered to grow at the fastest pace during the forecast period. The rising disposable income, infrastructural developments, and penetration of cutting-edge diagnostic technologies in Asian countries such as India and China offer significant growth opportunities for manufacturers and distributors of exosomes.

“North America: The North America region accounted for the largest share of the exosome research market”
North America accounted for the largest share of the exosome research market. The US is the key revenue contributor to the North American exosome research market. The high prevalence of cancer coupled with the increasing demand for early and effective disease diagnosis and treatment is the key factor driving market growth in the US.
Breakdown of primaries

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:
By Respondent– Supply Side- 40%, Demand Side- 60%
By Designation— Executives- 25%, CXOs & Directors–30%, Managers – 45%
By Region— North America – 40%, Europe – 25%, APAC – 20%, LATAM- 10%, MEA- 5%

Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Bio-Techne (US), System Biosciences, LLC. (US), NX PharmaGen (US), Miltenyi Biotec (Germany), AMS Biotechnology (Europe) Limited (UK), NanoSomiX (US), Lonza (Switzerland), and Norgen Biotek Corp. (Canada) are some of the leading players operating in the global exosome research market.

Research Coverage:

The report segments the exosome research market based on region (North America, Europe, Asia Pacific, and Rest of the World), Product & Service (Kits & Reagents (Antibodies, Isolation, Purification, Quantitation Kits & Reagents, Other Kits & Reagents), Instruments, Services), Indication (Cancer (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other Cancers), Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Other Cancers), Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Testing Laboratories).
The report also provides a comprehensive review of market drivers, challenges, and opportunities in the exosome research market.
Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the exosome research market and provides them information on key market drivers, challenges, and opportunities.


目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 28)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
FIGURE 1 EXOSOME RESEARCH MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 32)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 EXOSOME RESEARCH MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE): COLLECTIVE REVENUE OF EXOSOME RESEARCH IN THE MARKET
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
FIGURE 6 AVERAGE MARKET SIZE ESTIMATION, 2020
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 7 EXOSOME RESEARCH MARKET: CAGR PROJECTIONS, 2021–2026
FIGURE 8 EXOSOME RESEARCH MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS CHALLENGES, AND OPPORTUNITIES
FIGURE 9 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
FIGURE 11 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.6.1 COVID-19 SPECIFIC ASSUMPTIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. – 43)
FIGURE 12 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 EXOSOME RESEARCH MARKET, BY INDICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 14 EXOSOME RESEARCH MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 15 EXOSOME RESEARCH MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 GEOGRAPHICAL SNAPSHOT: EXOSOME RESEARCH MARKET

4 PREMIUM INSIGHTS (Page No. – 47)
4.1 EXOSOME RESEARCH MARKET OVERVIEW
FIGURE 17 RISING INVESTMENTS IN THE PHARMACEUTICAL INDUSTRY TO SUPPORT MARKET GROWTH
4.2 NORTH AMERICA: EXOSOME RESEARCH MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2020)
FIGURE 18 KITS & REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN EXOSOME RESEARCH MARKET IN 2020
4.3 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 19 LUNG CANCER SEGMENT TO DOMINATE THE MARKET IN 2026

5 MARKET OVERVIEW (Page No. – 49)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 EXOSOME RESEARCH MARKET: DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
TABLE 1 EXOSOME RESEARCH MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing investments in pharmaceutical R&D and life science research
5.2.1.2 Rising cancer prevalence
TABLE 2 GLOBAL CANCER INCIDENCE, 2020 VS. 2025
5.2.1.3 Increasing interest in exosome-based procedures
5.2.2 RESTRAINTS
5.2.2.1 Lack of skilled professionals
5.2.3 OPPORTUNITIES
5.2.3.1 Untapped emerging markets
5.2.3.2 Growing interest in exosome-based therapeutics
5.2.3.3 High demand for personalized medicine
5.2.4 CHALLENGE
5.2.4.1 Lack of gold standard protocols for development & production of exosomes
5.3 IMPACT OF COVID-19 OUTBREAK ON EXOSOME RESEARCH MARKET
TABLE 3 EXOSOME CONTRIBUTION IN COVID-19 CLINICAL RESEARCH
TABLE 4 ONGOING CLINICAL TRIALS FOR EXOSOME-BASED COVID-19 THERAPY
5.4 ECOSYSTEM AND VALUE CHAIN ANALYSIS
FIGURE 21 EXOSOME RESEARCH MARKET: ECOSYSTEM ANALYSIS
5.5 REGULATORY ANALYSIS

6 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE (Page No. – 60)
6.1 INTRODUCTION
TABLE 5 EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
6.2 KITS & REAGENTS
TABLE 6 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 8 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 9 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 10 EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS
6.2.1.1 Rapid and easy-to-use kits and reagents have gained significant demand in the past few years in the market
TABLE 11 EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 12 NORTH AMERICA: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 13 EUROPE: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 14 ASIA PACIFIC: EXOSOME RESEARCH ISOLATION, PURIFICATION, AND QUANTITATION KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 ANTIBODIES
6.2.2.1 High demand for exosome-based markers for disease detection is expected to propel the segment growth
TABLE 15 EXOSOME RESEARCH ANTIBODIES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 17 EUROPE: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 18 ASIA PACIFIC: EXOSOME RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 OTHER KITS & REAGENTS
TABLE 19 OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 20 NORTH AMERICA: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 21 EUROPE: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 22 ASIA PACIFIC: OTHER EXOSOME RESEARCH KITS & REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 SERVICES
6.3.1 PLAYERS OFFER END-TO-END RESEARCH SERVICES FOR LABS
TABLE 23 EXOSOME RESEARCH SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 24 NORTH AMERICA: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 25 EUROPE: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 26 ASIA PACIFIC: EXOSOME RESEARCH SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 INSTRUMENTS
6.4.1 DEMAND FOR SCALABLE DEVELOPMENT OF EXOSOMES VIA HIGH THROUGHPUT SYSTEMS AUGMENTS THE SEGMENT GROWTH
TABLE 27 EXOSOME RESEARCH INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 28 NORTH AMERICA: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 29 EUROPE: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 30 ASIA PACIFIC: EXOSOME RESEARCH INSTRUMENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)

7 EXOSOME RESEARCH MARKET, BY INDICATION (Page No. – 73)
7.1 INTRODUCTION
TABLE 31 EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
7.2 CANCER
TABLE 32 EXOSOME RESEARCH MARKET FOR CANCER, BY REGION, 2019–2026 (USD MILLION)
TABLE 33 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 35 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 36 EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
7.2.1 LUNG CANCER
7.2.1.1 Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth
TABLE 37 EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY REGION, 2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 EUROPE: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 40 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR LUNG CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.2 BREAST CANCER
7.2.2.1 High prevalence and increasing awareness to drive the market for this segment
TABLE 41 EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY REGION, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 43 EUROPE: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BREAST CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.3 PROSTATE CANCER
7.2.3.1 Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth
TABLE 45 EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY REGION, 2019–2026 (USD MILLION)
TABLE 46 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 47 EUROPE: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 48 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PROSTATE CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.4 COLORECTAL CANCER
7.2.4.1 Increasing research activities and projects based on exosomes to drive the market for this segment
TABLE 49 EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY REGION, 2019–2026 (USD MILLION)
TABLE 50 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 EUROPE: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 52 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2019–2026 (USD MILLION)
7.2.5 OTHER CANCERS
TABLE 53 EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY REGION, 2019–2026 (USD MILLION)
TABLE 54 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 55 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER CANCERS, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 NEURODEGENERATIVE DISEASES
7.3.1 POTENTIAL OF SALIVARY EXOSOMAL CONTENT AS BIOMARKERS HAS OPENED AVENUES IN RESEARCH FOR NEURODEGENERATIVE DISEASES
TABLE 57 EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY REGION, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR NEURODEGENERATIVE DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 CARDIOVASCULAR DISEASES
7.4.1 GROWING RESEARCH ON EXTRACELLULAR VESICLES FOR CVD TO PROPEL THE SEGMENT GROWTH
TABLE 61 EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2019–2026 (USD MILLION)
TABLE 62 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.5 INFECTIOUS DISEASES
7.5.1 POTENTIAL USE OF EXOSOMES IN DEVELOPING NOVEL COVID-19 TREATMENT SOLUTIONS IS EXPECTED TO DRIVE THE MARKET
TABLE 65 EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 67 EUROPE: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 68 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019–2026 (USD MILLION)
7.6 OTHER INDICATIONS
TABLE 69 EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 71 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 72 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

8 EXOSOME RESEARCH MARKET, BY APPLICATION (Page No. – 92)
8.1 INTRODUCTION
TABLE 73 EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
8.2 BIOMARKERS
8.2.1 BIOMARKERS FORM THE LARGEST APPLICATION SEGMENT
TABLE 74 EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY REGION, 2019–2026 (USD MILLION)
TABLE 75 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 76 EUROPE: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 77 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR BIOMARKERS, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 VACCINE DEVELOPMENT
8.3.1 POTENTIAL OF EXOSOMES TO COMBAT BACTERIAL INFECTIONS DRIVING INTEREST IN VACCINE APPLICATIONS
TABLE 78 EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY REGION, 2019–2026 (USD MILLION)
TABLE 79 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR VACCINE DEVELOPMENT, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 TISSUE REGENERATION
8.4.1 STUDIES CONDUCTED ON MOLECULAR PAYLOADS OF EXOSOMES TO ENHANCE TISSUE REGENERATION DRIVES MARKET GROWTH
TABLE 82 EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY REGION, 2019–2026 (USD MILLION)
TABLE 83 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 84 EUROPE: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 85 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR TISSUE REGENERATION, BY COUNTRY, 2019–2026 (USD MILLION)
8.5 OTHER APPLICATIONS
TABLE 86 EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 88 EUROPE: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 89 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2019–2026 (USD MILLION)

9 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE (Page No. – 101)
9.1 INTRODUCTION
TABLE 90 EXOSOME RESEARCH MARKET, BY MANUFACTURING SERVICE, 2019–2026 (USD MILLION)
9.2 STEM CELL-DERIVED EXOSOME MANUFACTURING SERVICES
9.2.1 INCREASED DEMAND FOR MSC-EXOSOMES IN THERAPEUTICS AUGMENTS THE SEGMENT GROWTH
9.3 DENDRITIC CELL-DERIVED EXOSOME MANUFACTURING SERVICES
9.3.1 SIGNIFICANT DEVELOPMENTS IN DC-EXOSOME IMMUNOTHERAPY TO DRIVE MARKET GROWTH
9.4 OTHER MANUFACTURING SERVICES

10 EXOSOME RESEARCH MARKET, BY END USER (Page No. – 104)
10.1 INTRODUCTION
TABLE 91 EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
10.2 ACADEMIC & RESEARCH INSTITUTES
10.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN THE EXOSOME RESEARCH MARKET
TABLE 92 EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 94 EUROPE: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 95 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3.1 SIGNIFICANT DEVELOPMENTS IN NANOMEDICINE TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT
TABLE 96 EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 97 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 98 EUROPE: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 99 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
10.4 HOSPITAL & CLINICAL TESTING LABORATORIES
10.4.1 INCREASE IN ADOPTION OF EXOSOME-BASED ONCOLOGY RESEARCH SOLUTIONS TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT
TABLE 100 EXOSOME RESEARCH MARKET FOR HOSPITAL & CLINICAL TESTING LABORATORIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 101 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 102 EUROPE: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 103 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)

11 EXOSOME RESEARCH MARKET, BY REGION (Page No. – 111)
11.1 INTRODUCTION
TABLE 104 EXOSOME RESEARCH MARKET, BY REGION, 2019–2026 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 22 NORTH AMERICA: EXOSOME RESEARCH MARKET SNAPSHOT
TABLE 105 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 106 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 107 NORTH AMERICA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 109 NORTH AMERICA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 111 NORTH AMERICA: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.1 US
11.2.1.1 High burden of cancer and favorable public and private funding for research activities to drive market growth
FIGURE 23 US CONTINUES TO DOMINATE THE DISTRIBUTION OF R&D COMPANIES BY REGION/COUNTRY (2021)
TABLE 112 US: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 113 US: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 US: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 115 US: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 US: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 117 US: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Increasing funding for genome-based medical treatments to support market growth
TABLE 118 CANADA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 119 CANADA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 CANADA: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 121 CANADA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 122 CANADA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 123 CANADA: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3 EUROPE
FIGURE 24 EUROPE: EXOSOME RESEARCH MARKET SNAPSHOT
TABLE 124 EUROPE: EXOSOME RESEARCH MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 125 EUROPE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 126 EUROPE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 EUROPE: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 128 EUROPE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 EUROPE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 130 EUROPE: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Strong academic research base bolsters market growth
TABLE 131 GERMANY: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 132 GERMANY: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 GERMANY: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 134 GERMANY: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 GERMANY: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 136 GERMANY: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.2 UK
11.3.2.1 Growth in the life sciences industry to drive the market for exosome research in the UK
TABLE 137 UK: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 138 UK: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 UK: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 140 UK: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 UK: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 142 UK: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Strong collaborative network between biotechnology entities and research institutes drives market growth
TABLE 143 FRANCE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 144 FRANCE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 FRANCE: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 146 FRANCE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 FRANCE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 148 FRANCE: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.3.4 REST OF EUROPE
TABLE 149 ROE: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 150 ROE: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 ROE: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 152 ROE: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 153 ROE: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 154 ROE: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4 ASIA PACIFIC
TABLE 155 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 156 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 157 ASIA PACIFIC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.1 CHINA
11.4.1.1 Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are major factors driving market growth
TABLE 162 CHINA: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 163 CHINA: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 164 CHINA: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 165 CHINA: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 166 CHINA: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 167 CHINA: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosome research market in the country
TABLE 168 JAPAN: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 169 JAPAN: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 JAPAN: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 171 JAPAN: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 172 JAPAN: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 173 JAPAN: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.4.3 REST OF ASIA PACIFIC
TABLE 174 ROAPAC: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 175 ROAPAC: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 ROAPAC: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 177 ROAPAC: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 178 ROAPAC: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 179 ROAPAC: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)
11.5 REST OF THE WORLD
TABLE 180 ROW: EXOSOME RESEARCH MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 181 ROW: EXOSOME RESEARCH KITS & REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 182 ROW: EXOSOME RESEARCH MARKET, BY INDICATION, 2019–2026 (USD MILLION)
TABLE 183 ROW: EXOSOME RESEARCH MARKET FOR CANCER, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 ROW: EXOSOME RESEARCH MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 185 ROW: EXOSOME RESEARCH MARKET, BY END USER, 2019–2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. – 147)
12.1 INTRODUCTION
12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 25 EXOSOME RESEARCH MARKET: STRATEGIES ADOPTED
12.3 MARKET SHARE ANALYSIS
FIGURE 26 EXOSOME RESEARCH MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
12.4 COMPANY EVALUATION QUADRANT
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
FIGURE 27 EXOSOME RESEARCH MARKET: COMPANY EVALUATION MATRIX, 2020 (TOP 10 PLAYERS)
12.5 COMPETITIVE BENCHMARKING
12.5.1 COMPANY SERVICE FOOTPRINT (10 COMPANIES)
FIGURE 28 SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS IN EXOSOME RESEARCH MARKET
12.6 COMPETITIVE SCENARIO AND TRENDS
12.6.1 DEALS (2016–2019)
TABLE 186 EXOSOME RESEARCH MARKET: DEALS
12.6.2 PRODUCT LAUNCHES (2016–2019)
TABLE 187 EXOSOME RESEARCH MARKET: PRODUCT LAUNCHES
12.6.3 OTHER DEVELOPMENTS (2016–2019)
TABLE 188 EXOSOME RESEARCH MARKET: OTHER DEVELOPMENTS

13 COMPANY PROFILES (Page No. – 155)
13.1 KEY COMPANIES
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
13.1.1 THERMO FISHER SCIENTIFIC, INC.
TABLE 189 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 190 THERMO FISHER SCIENTIFIC, INC.: PRODUCT OFFERINGS
TABLE 191 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS
13.1.2 SYSTEM BIOSCIENCES, LLC.
TABLE 192 SYSTEM BIOSCIENCES LLC: BUSINESS OVERVIEW
TABLE 193 SYSTEM BIOSCIENCES: PRODUCT & SERVICE OFFERINGS
TABLE 194 SYSTEM BIOSCIENCES LLC: DEALS
13.1.3 BIO-TECHNE
TABLE 195 BIO-TECHNE: BUSINESS OVERVIEW
FIGURE 30 BIO-TECHNE: COMPANY SNAPSHOT
TABLE 196 BIO-TECHNE: PRODUCT OFFERINGS
TABLE 197 BIO-TECHNE: PRODUCT LAUNCHES
TABLE 198 BIO-TECHNE: DEALS
13.1.4 QIAGEN
TABLE 199 QIAGEN: BUSINESS OVERVIEW
FIGURE 31 QIAGEN: COMPANY SNAPSHOT
TABLE 200 QIAGEN: PRODUCT OFFERINGS
TABLE 201 QIAGEN: DEALS
13.1.5 LONZA
TABLE 202 LONZA: BUSINESS OVERVIEW
FIGURE 32 LONZA: COMPANY SNAPSHOT
TABLE 203 LONZA: SERVICE OFFERINGS
TABLE 204 LONZA: DEALS
13.1.6 NX PHARMAGEN
TABLE 205 NX PHARMAGEN: BUSINESS OVERVIEW
TABLE 206 NX PHARMAGEN: SERVICE OFFERINGS
13.1.7 AMSBIO (AMS BIOTECHNOLOGY)
TABLE 207 AMSBIO: BUSINESS OVERVIEW
TABLE 208 AMSBIO: PRODUCT OFFERINGS
13.1.8 NANOSOMIX, INC.
TABLE 209 NANOSOMIX, INC.: BUSINESS OVERVIEW
TABLE 210 NANOSOMIX: PRODUCT OFFERINGS
13.1.9 MILTENYI BIOTEC
TABLE 211 MILTENYI BIOTEC: BUSINESS OVERVIEW
TABLE 212 MILTENYI BIOTEC: PRODUCT OFFERINGS
13.1.10 NORGEN BIOTEK CORP.
TABLE 213 NORGEN BIOTEK CORP.: BUSINESS OVERVIEW
TABLE 214 NORGEN BIOTEK: PRODUCT OFFERINGS
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13.2 OTHER PLAYERS
13.2.1 AETHLON MEDICAL, INC.
TABLE 215 AETHLON MEDICAL, INC.: COMPANY OVERVIEW
13.2.2 ANJARIUM BIOSCIENCES AG
TABLE 216 ANJARIUM BIOSCIENCES AG: COMPANY OVERVIEW
13.2.3 CILOA
TABLE 217 CILOA: COMPANY OVERVIEW
13.2.4 CLARA BIOTECH, INC.
TABLE 218 CLARA BIOTECH, INC.: COMPANY OVERVIEW
13.2.5 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
TABLE 219 CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.: COMPANY OVERVIEW
13.2.6 ILIAS BIOLOGICS, INC.
TABLE 220 ILIAS BIOLOGICS, INC.: COMPANY OVERVIEW
13.2.7 NANOVIEW BIOSCIENCES
TABLE 221 NANOVIEW BIOSCIENCES: COMPANY OVERVIEW
13.2.8 RION, LLC
TABLE 222 RION, LLC: COMPANY OVERVIEW
13.2.9 CELL GUIDANCE SYSTEMS LLC
TABLE 223 CELL GUIDANCE SYSTEMS: COMPANY OVERVIEW
13.2.10 INOVIQ (BARD1 LIFE SCIENCES LTD.)
TABLE 224 INOVIQ: COMPANY OVERVIEW
13.2.11 NOVUS BIOLOGICALS
TABLE 225 NOVUS BIOLOGICALS: COMPANY OVERVIEW
13.2.12 BIOVISION INC.
TABLE 226 BIOVISION INC.: COMPANY OVERVIEW
13.2.13 PALL CORPORATION
TABLE 227 PALL CORPORATION: COMPANY OVERVIEW
13.2.14 EXOPHARM
TABLE 228 EXOPHARM: COMPANY OVERVIEW
13.2.15 EVERZOM
TABLE 229 EVERZOM: COMPANY OVERVIEW

14 APPENDIX (Page No. – 185)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORT
14.5 AUTHOR DETAILS


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com